Breaks Categories: Stock Spotlights

WednesdayFeb 02, 2022 2:59 pm

CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space

InMed Pharmaceuticals (NASDAQ: INM) is a trailblazer, a pioneer defining the value of rare cannabinoids in the pharmaceutical sector and just how integral they are in pushing the industry forward. The global cannabis market is experiencing tremendous growth, particularly considering there are over 100 known cannabinoids, including rare ones that are quickly taking over and will soon dominate the market. The potency of rare cannabinoids has given them powerful health benefits, hence their demand within the cosmetics, food and beverage, health and wellness, and pharmaceutical sectors. “InMed’s most advanced compound, INM-755, has already proven helpful in treating epidermolysis bullosa, a…

Continue Reading

TuesdayFeb 01, 2022 1:49 pm

CBDNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Leadership Position Recognized in Food and Beverage, Cannabis Products Categories

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. In addition, BevCanna was also recognized as one of the Top 101 Cannabis Startups and Companies in Canada, among innovators and growth companies within the Canadian cannabis industry. A recent article quotes BevCanna CEO Marcello Leone as saying, “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy…

Continue Reading

WednesdayJan 26, 2022 1:38 pm

CBDNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strategically Pursuing Vertical Integration

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is riding the popularity of its trademarked Platinum Vape to remarkable revenue growth, recording a 93% year-over-year increase in its recently released third-quarter financial report. “The financial results note that the majority of the company’s revenue comes from sales of cannabis finished products through third-party wholesaling to retailers, delivering quarterly revenue of $11.8 million and EBITDA of $5.9 million that reverses an EBITDA loss of $5.8 million in Q3 2020 for a gain of $11.9 million,” reads a recent article, which also includes comments by RWB chairman and CEO Brad Rogers…

Continue Reading

FridayJan 21, 2022 2:20 pm

CBDNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Products Ready for New International Markets

Flora Growth Corp. (NASDAQ: FLGC) is entering 2022 with momentum from the past year’s aggressive growth campaign for its global cannabis-derivative brand distribution of pharmaceuticals, cosmetics and nutraceuticals. While the COVID-19 pandemic has had a deleterious effect on the global sustainability agenda, Flora Growth has prioritized value-chain sustainability among each of its brands, acting at a local level to establish products that will have a beneficial effect on communities and the world at large. Flora’s core product, organic cannabis oil, comes from an inherently sustainable process at the company’s cultivation site in central Colombia. “The company recently began filling the…

Continue Reading

FridayJan 14, 2022 12:50 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) to Deliver More Effective Oral Medicine

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of drug delivery platforms, is increasing the effectiveness of orally administered drugs. With oral absorption being the most convenient and widely used route for taking medications, decades of research have advanced the understanding of critical factors controlling oral bioavailability. Scientists are now better understanding the physiological function and formulation functionality that has been used in designing improved and more desirable oral medicine delivery through extensive research. Lexaria is accomplishing this through its patented DehydraTECH(TM) technology. “DehydraTECH improves the way that active pharmaceutical ingredients (‘APIs’) make their way into the bloodstream. This is…

Continue Reading

FridayJan 14, 2022 12:33 pm

CBDNewsBreaks – Marijuana Company of America Inc.’s (MCOA) Strong Financial Performance Reflects Successful Diversification Capabilities, Organic Growth

Marijuana Company of America (OTC: MCOA) is uniquely positioned to benefit from the cannabis market’s growth and associated opportunities as more states and countries worldwide push for the legalization of cannabis. MCOA offers diverse operations that include its cDistro distribution company, as well as hempsmart(TM) and VBF brands, a premium CBD company and a cannabis nursery cultivation facility in Salinas, California, respectively. In addition, the company is building its portfolio of investments and joint ventures, representing the highest standards of professionalism and integrity in the legal cannabis and industrial hemp markets. “MCOA recently reported a significant milestone, reaching the highest…

Continue Reading

ThursdayJan 13, 2022 3:05 pm

CBDNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Strong Financial Results Evidence Continued Execution, Brands’ Impact on Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently released its unaudited financial results for the fiscal quarter ended Sept. 30, 2021. The company saw revenues increase by more than 1,000% to $1.1 million with a gross profit of $356,168, a significant turnaround from the loss of $40,280 recorded in Q3 2020. A recent article quotes BevCanna Chief Financial Officer John Campbell as saying, “As we closed out the third quarter, we delivered impressive revenue growth of more than 1,000%, achieving $1.1 million in sales, compared to $94,000 in the…

Continue Reading

FridayJan 07, 2022 1:18 pm

CBDNewsBreaks – Marijuana Company of America Inc. (MCOA) Carving out Market Share, Tapping Strategic Partnerships

Marijuana Company of America (OTC: MCOA) recently released financial results for the three months ended Sept. 30, 2021 (“Q3 2021”), posting a 731% year-on-year increase compared to the same period in Q3 2020. Total revenue stood at $442,178 (up from $53,195), with gross profit to $63,687, up from $16,025 in Q3 2020, representing a 297% increase over that period. MCOA has attributed the impressive growth to its new acquisition of cDistro, a distribution enterprise, which positioned it to take advantage of immediate revenue granted by the opportunity to carve out a significant market share in the specialty distribution space. In…

Continue Reading

ThursdayJan 06, 2022 3:39 pm

CBDNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Expands White-Label Program to Add Averi Health Products

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently entered into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products. An emerging alternative beverage company, Averi Health Products was founded by Terry Donnelly, former CEO of the award-winning Hill Street Beverage Co. Catering to millennials’ changing preferences, with many choosing to consume less alcohol than preceding generations, Averi is focused on creating cannabis and hemp-infused adult beverage options directed at consumers with a discerning palate, who are unwilling to compromise on taste, complexity, sophistication or social…

Continue Reading

WednesdayJan 05, 2022 2:33 pm

CBDNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Innovative Portfolio Powers Research Insights

RYAH Group (CSE: RYAH) is the leader in volume-control technology for plant-based medicine. The company supports cannabis research for the treatment of cancer “with innovative technology that collects, analyzes and leverages objective data on therapeutic plant usage. By using the company’s smart devices and integrated AI-powered platform, patients and doctors can stay on top of prescription treatments in a safe, secure and seamless way,” reads a recent article. “RYAH’s current portfolio integrates IoT devices, medicine-carrying components and mobile applications to create an ecosystem that enables practitioners and patients to administer treatments, control volume, collect data and produce analytics that can…

Continue Reading